郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Systemic administration of tripeptidyl peptidase I in a mouse model of late infantile neuronal ceroid lipofuscinosis: effect of glycan modification.

期刊：PloS one发表年份：2012作者：Yu Meng; Istvan Sohar; Lingling Wang; David E Sleat; Peter Lobel
阅读更多 →

药效评价Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro.

期刊：British journal of pharmacology发表年份：2012作者：L S Whyte; L Ford; S A Ridge; G A Cameron; M J Rogers; R A Ross
阅读更多 →

药效评价The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55.

期刊：Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology发表年份：2012作者：Haleli Sharir; Linda Console-Bram; Christina Mundy; Steven N Popoff; Ankur Kapur; Mary E Abood
阅读更多 →

药效评价Cannabinoid CB(2) receptor attenuates morphine-induced inflammatory responses in activated microglial cells.

期刊：British journal of pharmacology发表年份：2012作者：Stefania Merighi; Stefania Gessi; Katia Varani; Debora Fazzi; Prisco Mirandola; Pier Andrea Borea
阅读更多 →